QOL Medical, LLC, the maker of Sucraid® (sacrosidase) Oral Solution, is committed to ensuring that Genetic Sucrase-Isomaltase Deficiency/Congenital Sucrase-Isomaltase Deficiency patients receive medication in a timely manner. SucraidASSIST™ (Acesss and Support Services in Sucraid Therapy) is a comprehensive program of services to ensure that all Genetic Sucrase-Isomaltase Deficiency patients can access Sucraid®.
SucraidASSIST™ (Access and Support Services in Sucraid Therapy) is a comprehensive program of support services for eligible US patients who need assistance with accessing Sucraid®. SucraidASSIST™ helps patients access Sucraid® and all related services through Patient Care Coordinators (PCCs). PCCs can provide assistance with: